These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
560 results:

  • 1. Biomarker Testing Disparities in Metastatic colorectal cancer.
    Sabbagh S; Herrán M; Hijazi A; Jabbal IS; Mohanna M; Dominguez B; Itani M; Sarna K; Liang H; Nahleh Z; Wexner SD; Nagarajan A
    JAMA Netw Open; 2024 Jul; 7(7):e2419142. PubMed ID: 38967928
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Are sporadic colorectal cancers in young patients distinct from those in elderly patients?
    Yang IJ; Kim DW; Lee J; Ahn HM; Oh HK; Kang SB; Suh JW; Kim MH; Oh HJ; Kim HK; Kim MJ; Park JW; Ryoo SB; Park KJ; Jeong SY; Oh JH
    Colorectal Dis; 2024 Jul; 26(7):1405-1414. PubMed ID: 38881232
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    El Zaitouni S; Laraqui A; Ghaouti M; Benzekri A; Kettani F; Bajjou T; Sekhsokh Y; Benmokhtar S; Jafari M; Baba W; Oukabli M; El Annaz H; Abi R; Tagajdid MR; El Kochri S; Lahlou IA; Ameziane El Hassani R; Ennibi K
    Cancer Control; 2024; 31():10732748241262179. PubMed ID: 38875469
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
    Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
    Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
    Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
    Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Outcomes in Patients With Krukenberg Tumors From colorectal cancer.
    Ostowari A; Hasjim BJ; Lim L; Yu J; Nguyen L; Dayyani F; Zell J; Cho M; Senthil M; Eng OS
    J Surg Res; 2024 Jul; 299():343-352. PubMed ID: 38795557
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Temporal trends and regional variability in BRAF and kras genetic testing in Denmark (2010-2022): Implications for precision medicine.
    Frost MG; Jensen KJ; Jimenez-Solem E; Qvortrup C; Kuhlmann TP; Andersen JL; Høgdall E; Petersen TS
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23236. PubMed ID: 38656617
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Adjuvant chemotherapy is associated with better oncological outcomes after ALPPS for colorectal liver metastases.
    Alvarez FA; Ardiles V; Chara C; de Santibañes M; Sánchez Clariá R; Pekolj J; de Santibañes E
    Updates Surg; 2024 Jun; 76(3):855-868. PubMed ID: 38647857
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinicopathological characteristics of Lynch-like syndrome.
    Nakamori S; Takao M; Takao A; Natsume S; Iijima T; Kojika E; Nakano D; Kawai K; Inokuchi T; Fujimoto A; Urushibara M; Horiguchi SI; Ishida H; Yamaguchi T
    Int J Clin Oncol; 2024 Jul; 29(7):944-952. PubMed ID: 38642190
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 11. Circular RNAs in the kras pathway: Emerging players in cancer progression.
    Hussain MS; Moglad E; Afzal M; Bansal P; Kaur H; Deorari M; Ali H; Shahwan M; Hassan Almalki W; Kazmi I; Alzarea SI; Singh SK; Dua K; Gupta G
    Pathol Res Pract; 2024 Apr; 256():155259. PubMed ID: 38503004
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Noninvasive Stratification of Colon cancer by Multiplex PET Imaging.
    Malviya G; Lannagan TRM; Johnson E; Mackintosh A; Bielik R; Peters A; Soloviev D; Brown G; Jackstadt R; Nixon C; Gilroy K; Campbell A; Sansom OJ; Lewis DY
    Clin Cancer Res; 2024 Apr; 30(8):1518-1529. PubMed ID: 38493804
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic colorectal cancer: A Multicenter Retrospective Comparative Study.
    Bazarbashi S; Alkhatib R; Aseafan M; Tuleimat Y; Abdel-Aziz N; Mahrous M; Elsamany S; Elhassan T; Alghamdi M
    JCO Glob Oncol; 2024 Mar; 10():e2300461. PubMed ID: 38484194
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Twelve-month progression-free survival with sotorasib and panitumumab in kras G12C mutant metastatic colorectal cancer.
    Kavgaci G; Dizdar O; Yalcin S
    Anticancer Drugs; 2024 Jun; 35(5):459-461. PubMed ID: 38451823
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Extended Enrichment for Ultrasensitive Detection of Low-Frequency Mutations by Long Blocker Displacement Amplification.
    Si Y; Wang X; Su X; Weng Z; Hu Q; Li Q; Fan C; Zhang DY; Wang Y; Luo S; Song P
    Angew Chem Int Ed Engl; 2024 May; 63(19):e202400551. PubMed ID: 38416545
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine MA; More A; Fanaeian M; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine FA; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally CP; Kee B; Kopetz S; Goldstein D; Strach M; Williamson A; Aziz O; Barriuso J; Uppal A; White MG; Helmink B; Fournier KF; Raghav KP; Taggart MW; Overman MJ; Shen JP
    JAMA Netw Open; 2024 Feb; 7(2):e240260. PubMed ID: 38416491
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical features and mutation analysis of class 1/2/3 BRAF mutation colorectal cancer.
    Huang Y; Jia W; Zhao G; Zhao Y; Zhang S; Li Z; Wu G
    Chin Clin Oncol; 2024 Feb; 13(1):3. PubMed ID: 38372057
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 28.